1. Home
  2. EOLS vs IVR Comparison

EOLS vs IVR Comparison

Compare EOLS & IVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • IVR
  • Stock Information
  • Founded
  • EOLS 2012
  • IVR 2008
  • Country
  • EOLS United States
  • IVR United States
  • Employees
  • EOLS N/A
  • IVR N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • IVR Real Estate Investment Trusts
  • Sector
  • EOLS Health Care
  • IVR Real Estate
  • Exchange
  • EOLS Nasdaq
  • IVR Nasdaq
  • Market Cap
  • EOLS 493.5M
  • IVR 493.9M
  • IPO Year
  • EOLS 2018
  • IVR 2009
  • Fundamental
  • Price
  • EOLS $7.66
  • IVR $7.99
  • Analyst Decision
  • EOLS Strong Buy
  • IVR Hold
  • Analyst Count
  • EOLS 5
  • IVR 2
  • Target Price
  • EOLS $21.25
  • IVR $7.50
  • AVG Volume (30 Days)
  • EOLS 1.2M
  • IVR 1.3M
  • Earning Date
  • EOLS 11-05-2025
  • IVR 11-04-2025
  • Dividend Yield
  • EOLS N/A
  • IVR 17.04%
  • EPS Growth
  • EOLS N/A
  • IVR N/A
  • EPS
  • EOLS N/A
  • IVR 0.32
  • Revenue
  • EOLS $277,941,000.00
  • IVR $59,701,000.00
  • Revenue This Year
  • EOLS $14.01
  • IVR $278.42
  • Revenue Next Year
  • EOLS $29.46
  • IVR N/A
  • P/E Ratio
  • EOLS N/A
  • IVR $25.15
  • Revenue Growth
  • EOLS 17.15
  • IVR 1793.56
  • 52 Week Low
  • EOLS $5.71
  • IVR $5.86
  • 52 Week High
  • EOLS $17.82
  • IVR $9.42
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 50.21
  • IVR 63.76
  • Support Level
  • EOLS $7.19
  • IVR $7.57
  • Resistance Level
  • EOLS $7.67
  • IVR $7.83
  • Average True Range (ATR)
  • EOLS 0.34
  • IVR 0.12
  • MACD
  • EOLS 0.13
  • IVR 0.03
  • Stochastic Oscillator
  • EOLS 79.29
  • IVR 83.00

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About IVR INVESCO MORTGAGE CAPITAL INC

Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.

Share on Social Networks: